Manufacturing

Articles

Edge-AI technology will enable Industry 4.0 automation in pharmaceutical manufacturing.

Neurala Partners with IMA Group on AI for Manufacturing Automation

Honeywell Forge Cybersecurity Suite’s improved industrial-grade remote access and added protection and risk monitoring aids remote operations.

New Cybersecurity Features Protect Facilities with Remote Operations

Automated sampling systems and integration of PAT are overcoming some of the roadblocks to increased automation of biopharmaceutical manufacturing processes.

New Tools Facilitate Automated Process Control

Ori Biotech is partnering with manufacturers and materials suppliers to develop an automated system for cell and gene therapy manufacturing. 

Ori Biotech and CellGenix Collaborate on Closed-System, Cell and Gene Therapy Manufacturing

MilliporeSigma’s Bio4C Software Suite combines process control, analytics, and plant-level automation.

Data Visualization and Analysis Software Enables Real-Time Manufacturing Intelligence

Enhancements to Augury’s AI-based machine health platform include new capabilities and collaboration tools for personnel working remotely.

Augury Adds Capabilities to Machine Health Platform

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Ensuring the quality of data in process monitoring and control systems starts in process development phases.

Building Data Quality in Generates Quality Data Out

Sartorius and the German Research Center for Artificial Intelligence have established a research laboratory for AI in the biopharmaceutical industry.

Sartorius and German Research Center Collaborate on Artificial Intelligence

In batch production, efficient exception management means reducing the time required to identify, review, and resolve process exceptions. Incorporating review by exception functionality within manufacturing execution system (MES) software can streamline biopharmaceutical product release.


Review by Exception: Connecting the Dots for Faster Batch Release

Agnes Shanley is senior editor of BioPharm International.

Bob Lenich, Emerson's business director for global life sciences, shares insights on where biopharma modeling is now, and where it is heading in the near future.


Process Control, Automation, and PAT